Saturday, May 4, 2024

No Result

View All Result

Media

No Result

View All Result

Columns

Why Canada spends so much on health care and still has a crisis: Nigel Rawson and John Adams in the Globe and Mail

March 6, 2024

John Adams

Inside Policy

Waiting for new drugs for rare disorders in Canada – part 3, price negotiation: Nigel Rawson and John Adams for Inside Policy

July 26, 2023

Inside Policy

Waiting for new drugs for rare disorders in Canada – part 2, health technology assessment: Nigel Rawson and John Adams for Inside Policy

July 19, 2023

Inside Policy

Waiting for new drugs for rare disorders in Canada – part 1, regulatory approval: Nigel Rawson and John Adams for Inside Policy

July 12, 2023

The U.S. outsources control of drug prices to Canada: weird! Richard Owens in the Financial Post

Columns

The drug prices review board was once a solution. It’s now a problem: Nigel Rawson and John Adams in the Financial Post

March 1, 2023

Columns

For drug access, Canadians with rare disorders are 40 years behind Americans: Nigel Rawson and John Adams in the Financial Post

January 24, 2023

Can we afford National Pharmacare and do people want it? Jeffrey Simpson for Inside Policy

Columns

PMPRB continues plan to drive down drug prices as patients suffer: Nigel Rawson and John Adams for Inside Policy

November 23, 2022

Build health care back better: Philip Cross in the Financial Post

Columns

Suffer from a rare disorder in Canada? Good luck: Nigel Rawson and John Adams in the Financial Post

November 2, 2022

The Patented Medicine Prices Review Board is selling Canadians a lemon: Nigel Rawson for Inside Policy

Health

Ottawa should reset its relationship with drug developers to improve patient health: Rawson and Adams for Inside Policy

May 2, 2022

Health

‘Big Tobacco’ COVID-19 vaccine: What were the Liberals thinking? Nigel Rawson and John Adams in the Financial Post

April 22, 2022

Domestic Policy

The Macdonald-Laurier Institute Welcomes Newest Senior Fellows, Nigel Rawson and John Adams

April 11, 2022

Page 2 of 2 Prev 1 2

Newsletter Signup

Email Address *

First Name *

Last Name *

*Required Fields

Follow us on

Macdonald-Laurier Institute

Support Us

Support the Macdonald-Laurier Institute to help ensure that Canada is one of the best governed countries in the world. Click below to learn more or become a sponsor.

Support Us

No Result

View All Result

Why Canada spends so much on health care and still has a crisis: Nigel Rawson and John Adams in the Globe and Mail

John Adams

Waiting for new drugs for rare disorders in Canada – part 3, price negotiation: Nigel Rawson and John Adams for Inside Policy

Waiting for new drugs for rare disorders in Canada – part 2, health technology assessment: Nigel Rawson and John Adams for Inside Policy

Waiting for new drugs for rare disorders in Canada – part 1, regulatory approval: Nigel Rawson and John Adams for Inside Policy

The drug prices review board was once a solution. It’s now a problem: Nigel Rawson and John Adams in the Financial Post

For drug access, Canadians with rare disorders are 40 years behind Americans: Nigel Rawson and John Adams in the Financial Post

PMPRB continues plan to drive down drug prices as patients suffer: Nigel Rawson and John Adams for Inside Policy

Suffer from a rare disorder in Canada? Good luck: Nigel Rawson and John Adams in the Financial Post

Ottawa should reset its relationship with drug developers to improve patient health: Rawson and Adams for Inside Policy

‘Big Tobacco’ COVID-19 vaccine: What were the Liberals thinking? Nigel Rawson and John Adams in the Financial Post

The Macdonald-Laurier Institute Welcomes Newest Senior Fellows, Nigel Rawson and John Adams

Top News

The Liberals are not going to fix Canada’s real defence spending problem: Richard Shimooka in the Hub

Canada Does a Poor Job Stewarding Our Energy Future: Nanos Research Poll

Double Trouble – Goodbye globalization? Balkan Devlen with Elisabeth Braw for Inside Policy Talks

Multimedia

How a trans activist group undermined medical science: Aaron Wudrick and Mia Hughes for Inside Policy Talks

Hon. Tony Abbott in conversation with Brian Lee Crowley

Billionaire Igor Makarov wants off Canada’s Russia sanctions list: Marcus Kolga on Global News

Time for an intervention – an urgent call to end “gender-affirming” treatments for children: J. Edward Les for Inside Policy

The Governor General deserves better, but we deserve impartiality: Philippe Lagassé for Inside Policy

Canadian Competitiveness in Resource Development – A Post-Mortem: Heather Exner-Pirot

Widespread shortages, skyrocketing costs: the growing calamity that is government-controlled child care

Success assured? Appraising the Canadian-led Enhanced Forward Presence battlegroup in Latvia

Newsletter Signup

Follow us on

Macdonald-Laurier Institute

Support Us